No-Cost, No-Obligation
Talcum Powder
Ovarian Cancer
Lawsuit Case Review

Talcum Powder Cancer Lawsuit Center

Who Can File a Talcum Powder Ovarian Cancer Lawsuit?


Talcum Powder Ovarian Cancer Lawsuit News

New Baby Powder Lawsuit Filed In Louisiana

A talcum powder lawsuit alleging negligence on the party of Johnson & Johnson was filed in Louisiana.

Monday, January 23, 2017 - A new talcum powder ovarian cancer lawsuit has been filed in the Eastern District of Louisiana federal court, one of the first of the new year. The Johnson & Johnson's baby powder lawsuit claims that the health care company failed to warn the plaintiff of the cancerous elements within the popular cosmetic. Citing more than 20 medical studies backing up the claim, the plaintiff is seeking to recover damages from the company for the ovarian cancer believed to have been caused by Johnson & Johnson's talcum powder. The woman who suffered from the disease died in 2001, and it is her husband that is bringing the claim against Johnson & Johnson.

The talcum powder attorneys representing Sebastian Ferman and his wife Carol claim that Johnson & Johnson should be held responsible for the ovarian cancer that Mrs. Ferman contracted. Citing the medical studies that have been conducted worldwide, in addition to a number of Johnson & Johnson internal documents recovered detailing inside knowledge of the talcum powder problem, the case is hoping to win damage for the plaintiff for the suffering and loss of life endured.

The talcum powder cancer lawsuit also points out that the product was advertising to consumers messages regarding the use as a genital hygiene for women. This is the exact fashion in which the product can cause a great deal of harm to women, and accompanied with this fact were messages detailing how safe and reliable the product was. These messages appeared without any mention of the cancer causing nature of the product. The talcum powder lawyers believe this counts as negligence, and lead to Mrs. Ferman's wrongful death.

The lawsuit was originally filed in Louisiana, although an MDL for Johnson & Johnson's talcum powder ovarian cancer lawsuits was created in November. Federal lawsuits that are filed will now be transferred to the U.S. District Court for the District of New Jersey. The Ferman talcum powder lawsuit will be headed there to join similar claims as the MDL process combines their shared aim and streamlines the pretrial process.

There has already been a number of examples that should promote hope for the plaintiff's talcum powder attorneys. Though this case may never go to trial, the ones that did in 2016 received a combined $197 million in damages. Juries in St. Louis where all the trials were heard sided strongly with the plaintiffs in giving them such large awards, especially considering the $197 million was divided between just three plaintiffs. These decisions have most who filed talcum powder lawsuits feeling optimistic about their legal future regarding ovarian cancer and talcum powder.

The Ferman's talcum powder cancer lawsuit was filed on January 12 and will join a growing number of similar claims around the country. There is no word yet on a lump sum settlement for the Johnson & Johnson's lawsuits currently pending, though a new trial that has just begun will likely have a sizeable effect on that avenue as a potential outcome for the litigation. The talcum powder MDL was consolidated in early October of 2016.

Information provided by, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.